Recombinant Human Anti-malaria antigen x Human Anti-TLR1 Bispecific Antibody (scFv-Fc) (BSCFV-H345)

Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-malaria antigen specificity or anti-TLR1 specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can retarget professional antigen-presenting cells (APCs) including DCs or NK cells to malaria antigen. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

malaria antigen & TLR1

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

malaria antigen

Alternative Names

malaria antigen; parasitic protozoans

Target 2

TLR1

Gene ID

7096

UniProt ID

Q15399

Alternative Names

CD281; TIL; TIL. LPRS5; rsc786; TLR1; Toll-like receptor 1; TLR

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "malaria antigen & TLR1"

See other bsAb targets related to "malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-malaria antigen x Human Anti-TLR1 Bispecific Antibody (scFv-Fc) (BSCFV-H345). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-malaria antigen x Human Anti-TLR1 Bispecific Antibody (scFv-Fc) (CAT#: BSCFV-H345)

Specifications

Targets

Customer Reviews and Q&As